Liraglutide 10mg is a synthetic peptide analogue of human GLP-1, engineered for a prolonged half-life. This compound is a high-purity active pharmaceutical ingredient (API) intended for research, laboratory, and manufacturing use.

In clinical applications, Liraglutide functions by mimicking the effects of the endogenous incretin hormone GLP-1. It stimulates glucose-dependent insulin secretion, suppresses inappropriate glucagon release, and slows gastric emptying. This mechanism of action makes it a cornerstone for investigating therapies for metabolic disorders.

Key Applications & Research Areas:

• Glycemic Control: Studies on improving blood sugar levels in type 2 diabetes.

• Weight Management: Research into its effects on appetite suppression and chronic weight management.

• Cardiovascular Health: Investigating its role in reducing the risk of major adverse cardiovascular events in patients with type 2 diabetes.

This product is provided as 10mg of lyophilized (freeze-dried) powder for reconstitution. It is not intended for direct human or veterinary use and should be handled by qualified professionals in a controlled laboratory setting.

CAS Number: 204656-20-2